Literature DB >> 26296958

One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension?

Brian A Houston1, Rohan J Kalathiya2, Gerin R Stevens1, Stuart D Russell1, Ryan J Tedford1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26296958     DOI： 10.1016/j.healun.2015.07.004

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  2 in total

1.  Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis.

Authors:  E Wilson Grandin; Gaurav Gulati; Jose I Nunez; Kevin Kennedy; J Eduardo Rame; Pavan Atluri; Francis D Pagani; James K Kirklin; Robert L Kormos; Jeffrey Teuteberg; Michael S Kiernan
Journal:  Circ Heart Fail       Date:  2022-03-25       Impact factor: 10.447

2.  Pulmonary hypertension due to left heart disease.

Authors:  Jean-Luc Vachiéry; Ryan J Tedford; Stephan Rosenkranz; Massimiliano Palazzini; Irene Lang; Marco Guazzi; Gerry Coghlan; Irina Chazova; Teresa De Marco
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.